SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-002169
Filing Date
2019-01-22
Accepted
2019-01-22 06:21:26
Documents
1
Period of Report
2019-01-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K tv511304_8k.htm 8-K 14032
  Complete submission text file 0001144204-19-002169.txt   15306
Mailing Address 2980 BEVERLY GLEN CIRCLE SUITE 301 LOS ANGELES CA 90077
Business Address 2980 BEVERLY GLEN CIRCLE SUITE 301 LOS ANGELES CA 90077 310-474-9809
Targeted Medical Pharma, Inc. (Filer) CIK: 0001420030 (see all company filings)

IRS No.: 205863618 | Fiscal Year End: 1209
Type: 8-K | Act: 34 | File No.: 000-53071 | Film No.: 19534191
SIC: 2834 Pharmaceutical Preparations